Data + Perspectives: The Current and Future Role of Immune
Checkpoint Inhibitors and Other Novel Therapies in the Management
of Gynecologic Cancers — Interview with Dr Tewari on the following
topic:
Selection and sequencing of therapies for metastatic cervical
cancer; mechanism of action, efficacy and tolerability of tisotumab
vedotin (00:00)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.